A review of executive function deficits and pharmacological management in children and adolescents

Journal of the Canadian Academy of Child and Adolescent Psychiatry

Volumn 21, Issue 3, 2012, Pages 223-229

  Hosenbocus, Sheik ^a   Chahal, Raj ^a  

^a ROYAL INLAND HOSPITAL   (Canada)

Author keywords

Adolescents; Children; Deficits; Executive; Function; Pharmacology

Indexed keywords

ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATOMOXETINE; ATYPICAL ANTIPSYCHOTIC AGENT; DEXAMPHETAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; LITHIUM; METHYLPHENIDATE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID;

ADOLESCENT; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; CHILD; COMPULSION; DEPRESSION; DISORDERS OF HIGHER CEREBRAL FUNCTION; DRUG APPROVAL; DRUG EFFICACY; EXECUTIVE FUNCTION; EXECUTIVE FUNCTION DEFICIT; FETAL ALCOHOL SYNDROME; HUMAN; MENTAL DISEASE; NEUROBIOLOGY; NEUROCHEMISTRY; OBSESSIVE COMPULSIVE DISORDER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCHIZOPHRENIA; SINGLE DRUG DOSE; SYSTEMATIC REVIEW;

EID: 84864804936     PISSN: 17198429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Andres, S., Boget, T., Lazaro, L., Penades, R., Morer, A., Salamero, M., & Castro-Fornieles, J. (2007). Neuropsychological performance in children and adolescents with obsessive compulsive disorder and influence on clinical variables. Biological Psychiatry, 61(8), 946-951.
2. Arnsten, A. (2009). Toward a new understanding of Attention-Deficit Hyperactivity Disorder Pathophysiology: An important role for prefrontal cortex dysfunction. CNS Drugs, 23(1), 33-41.
3. Barkley, R. (2012). The important role of executive functioning and self-regulation in ADHD. (PDF Document). Retrieved on April 02, 2012, from Russell A. Barkley, Ph.D.: The Official Site: http://www. russellbarkley.org/content/ADHD_EF_and_SR.pdf.
4. Carrasco, M., Volkmar, F. R., & Bloch, M. H. (2012). Pharmacologic Treatment of Repetitive Behaviors in Autism Spectrum Disorders: Evidence of Publication Bias. Pediatrics, 129(5), 1301-1310.
5. Castaneda, A., Suvisaari, J., Mattunen, M., Perala, J., Saarni, S., Aalto-Setala, T., & Lonnqvist, J. (2011). Cognitive functioning in a population-based sample of young adults with anxiety disorders. European Psychiatry, 26(6), 346-353.
6. Chang, S., McCracken, J., & Piancentini, J. (2007). Neurocognitive correlates of child Obsessive Compulsive Disorder and Tourette Syndrome. Journal of Clinical and Experimental Neuropsychology, 29(7), 724-733.
7. Cohen, B., & Carlezon, W. (2007). Can't get Enough of that Dopamine. Archives of General Psychiatry, 164(4), 543-546.
8. Cuesta, M. J., Peralta, V., & Zarzuela, A. (2001). Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: A longitudinal study. Schizophrenia Research, 48(1), 17-28.
9. Denys, D., Zohar, J., & Westenberg, H. (2004). The role of dopamine in Obsessive-Compulsive Disorder: Preclinical and clinical evidence. The Journal of Clinical Psychiatry, 65(Suppl 14), 11-17.
10. Douglas-Hall, P., Curran, S., & Bird, V. (2011). Aripiprazole: A review of its use in the treatment of irritability associated with autistic disorder patients aged 6-17. Journal of Central Nervous System Disease, 3, 143-153.
11. Dunlop, B., & Nemeroff, C. (2007). The role of dopamine in the pathophysiology of Depression. Archives of General Psychiatry, 64(3), 327-337.
12. Efron, D., Hiscock, H., Sewell, J., Cranswick, N., Vance, A., Tyl, Y., & Luk, E. (2003). Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists. Pediatrics, 111(2), 372-375.
13. Elliott, R. (2003). Executive functions and their disorders. British Medical Bulletin, 65(1), 45-59.
14. Ernst, M., Zametkin, A. J., Matochik, J. A., Pascualvaca, D., & Cohen, R. M. (1997). Low medial prefrontal dopaminergic activity in autistic children. Lancet, 350(9078), 638.
15. Fava, M. (2003). Symptoms of fatigue and cognitive/executive dysfunction in major Depressive Disorder before and after antidepressant treatment. Journal of Clinical Psychiatry, 64(14), 30-34.
16. Frankel, F., Paley, B., Marquardt, R., & O'Connor, M. (2006). Stimulants, Neuroleptics, and Children's Friendship Training for Children with Fetal Alcohol Spectrum Disorders. Journal of Child and Adolescent Psychopharmacology, 16(6), 777-789.
17. Goetghebeur, P., & Dias, R. (2009). Comparison of Haloperidol, Risperidone, Sertindole, and Modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat-a back translational study. Psychopharmacology, 202(1-3), 287-293.
18. Goldberg, J., & Chengappa, K. (2009). Identifying and treating cognitive impairment in Bipolar Disorder. Bipolar Disorders, 11(2), 123-137.
19. Gorlyn, M., Keilp, J., Grunebaum, M., Taylor, B., Oquendo, M., Bruder, G., & Mann, J. (2008). Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects. Journal of Neural Transmission, 115(8), 1213-1219.
20. Green, C., Mihic, A., Nikkel, S., Stade, B., Rasmussen, C., Munoz, D., & Reynolds, J. (2009). Executive function deficits in children with Fetal Alcohol Spectrum Disorders (FASD) measured using the Cambridge Neuropsychological Tests Automated Battery (CANTAB). Journal of Child Psychology and Psychiatry, 50(6), 688-697.
21. Green, T., Weinberger, R., Diamond, A., Berant, M., Hirshfield, L., Frisch, A., Gothelf, D. (2011). The effect of methylphenidate on prefrontal cognitive functioning, inattention and hyperactivity in Velocardiofacial Syndrome. Journal of Child and Adolescent Psychopharmacology, 21(6), 589-595.
22. Greene, R. (2005). The explosive child: a new approach for understanding and parenting easily frustrated, chronically inflexible children. New York: Harper Collins, Publishers.
23. Happe, F., Booth, R., Charlton, R., & Hughes, C. (2006). Executive function deficits in Autism Spectrum Disorders and Attention-Deficit/ Hyperactivity Disorder: Examining Profiles across Domains and Ages. Brain and Cognition, 61(1), 25-39.
24. Hartwell, N. (2001). The neuropsychology of suicidal states in depressed inpatients; Dissertation Abstracts International: Section B: The Sciences and Engineering, 66(11), 6136.
25. Harvey, P. D., Napolitano, J. H., Mao, L., & Gharabawi, G. (2003). Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder. International Journal of Geriatric Psychiatry, 18(9), 820-829.
26. Harvey, P., Siu, C., & Romano, S. (2004). Randomized, controlled, double-blind multicenter comparison of the cognitive effects of Ziprasidone versus Olanzapine in acutely ill patients with Schizophrenia or Schizoaffective disorder. Psychopharmacology, 172(3), 324-332.
27. Hill, E. L. (2004). Evaluating the theory of executive dysfunction in autism. Developmental Review, 24(2), 189-233.
28. Hosenbocus, S., & Chahal, R. (2009). A review of long-acting medications for ADHD in Canada. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 18(4), 331-339.
29. Huey, E., Putman, K., & Grafman, J. (2006). A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology, 66(1), 17-22.
30. Jones, R. (2000). Treating Attention Deficit Disorder as an Executive Function Disorder. Retrieved on April 3, 2012, from Serendip: http:// serendip.brynmawr.edu/bb/neuro/neuro00/web1/Jones.html.
31. Jurado, M., & Roselli, M. (2007). The elusive nature of executive functions: a review of our current understanding. Neuropsychological Review, 17(3), 213-233.
32. Kempton, S., Vance, A., Maruff, P., Luk, E., Costin, J., & Pantelis, C. (1999). Executive function and Attention Deficit Hyperactivity Disorder: Stimulant medication and better executive function in children. Psychological Medicine, 29(3), 527-538.
33. Kolevzon, A., Mathewson, K., & Hollander, E. (2006). Selective serotonin reuptake inhibitors in Autism: A review of efficacy and tolerability. The Journal of Clinical Psychiatry, 67(3), 407-414.
34. Malone, R. P., Gratz, S. S., Delaney, M. A., & Hyman, S. B. (2005). Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders. CNS Drugs, 19(11), 923-934.
35. Marsh, L., Biglan, K., Gertenhaber, M., & Williams, J. (2009). Atomoxetine for the treatment of executive dysfunction in Parkinson's Disease: A pilot open-label study. Movement Disorders, 24(2), 277-282.
36. Mattson, S., Goodman, A., Caine, C., Delis, D., & Riley, E. (1999). Executive functioning in children with heavy prenatal alcohol exposure. Alcoholism: Clinical and Experimental Research, 23(11), 1808-1815.
37. McCracken, J., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M., & McMahon, D. (2002). Risperidone in children with Autism and serious behavioral problems. New England Journal of Medicine, 347(5), 314-321.
38. McGurk, S., Lee, M., Jayathilake, K., & Meltzer, H. (2004). Cognitive effects of Olanzapine treatment in Schizophrenia. Medscape General Medicine, 6(2), 27.
39. McLennan, S., & Mathias, J. (2010). The depression-executive dysfunction (DED) syndrome and response to antidepressants: A metaanalytic review. International Journal of Geriatric Psychiatry, 25(10), 933-944.
40. Mendell, D. S., Knashawn, H. M., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E. (2008). Psychotropic medication use among medicaid-enrolled children with Autism Spectrum Disorders. Pediatrics, 121(3), 441-448.
41. Meyer, S., Carlson, G., Wiggs, E., Martinez, P., Ronsaville, D., Klimes-Dougan, B., Radke-Yarrow, M. (2004). A prospective study of the association among impaired executive functioning, childhood attentional problems, and the development of Bipolar Disorder. Development and Psychopathology, 16(2), 461-476.
42. Mur, M., Portella, M., Martinez-Aran, A., Pfifarre, J., & Vieta, E. (2007). Persistent neuropsychological deficit in euthymic bipolar patients. Journal of Clinical Psychiatry, 68(70), 1078-1086.
43. Narushima, K., Paradiso, S., Moser, D., Jorge, R., & Robinson, R. (2007). Effect of antidepressant therapy on executive function after stroke. British Journal of Psychiatry, 190(3), 260-265.
44. O'Grada, C., & Dinan, T. (2007). Executive function in Schizophrenia: What impact do antipsychotics have? Human Psychopharmacology: Clinical and Experimental, 22(6), 397-406.
45. Ornstein, T., Arnold, P., Manassis, K., Mendlowitz, S., & Schachar, R. (2010). Neuropsychological performance in childhood OCD: A preliminary study. Depression and Anxiety, 27(4), 372-380.
46. Ozonoff, S., Cook, I., Coon, H., Dawson, G., Joseph, R., Klin, A., Wrathall, D. (2004). Performance on Cambridge Neuropsychological Test automated battery subtests sensitive to frontal lobe function in people with Autistic Disorder: Evidence from the Collaborative Programs of Excellence in Autism Network. Journal of Autism and Developmental Disorders, 34(2), 139-150.
47. Parikh, M., Kolevzon, A., & Hollander, E. (2008). Psychopharmacology of aggression in children and adolescents with Autism: A critical review of efficacy and tolerability. Journal of Child and Adolescent Psychopharmacology, 18(2), 157-178.
48. Parker, C. (2011). ADHD and Cognitive Anxiety-Now 3 Types. Retrieved on April 2, 2012, from CorePsych Blog: http://www. corepsychblog.com/2011/12/adhd-and-cognitive-anxiety/.
49. Parker, L. (2001). Executive functions. Tourette syndrome "plus". Retrieved from LD Online: http://www.ldonline.org/article/6311/.
50. Rasmussen, C., & Bisanz, J. (2009). Executive functioning in children with Fetal Alcohol Spectrum disorders: Profiles and age-related differences. Child Neuropsychology, 15(3), 201-215.
51. Roberts, E. (2006). Executive function and dysfunction: Part 2-psychopharmacology for executive dysfunction. (Second Messenger). Psychopharmacology Educational Updates, 2(7), 5.
52. Robinson, S., Goddard, L., Dritschel, B., Wisley, M., & Howlin, P. (2009). Executive functions in children with Autism Spectrum Disorders. Brain and Cognition, 71(3), 362-368.
53. Rosenblatt, A., & Hopkins, J. (2006). Executive Dysfunction/sleep in the elderly. Audio-Digest Psychiatry, 35(20). Retrieved on April 4, 2012, from: http://www.cme-ce-summaries.com/psychiatry/ps3520.html.
54. Royall, D., Lauterbach, E., Cummings, J., Reeve, A., Rummans, T., Kaufer, D., Coffey, C. (2002). Executive control function: A review of its promise and challenges for clinical research. A report from the committee on research of the American Neuropsychiatric Association. Journal of Neuropsychiatry and Clinical Neuroscience, 14(4), 377-406.
55. Snyder, A., Maruff, P., Pietrzak, R., Cromer, J., & Snyder, P. (2008). Effect of treatment with stimulant medication on nonverbal executive function and visuomotor speed in children with Attention-Deficit/ Hyperactivity Disorder (ADHD). Child Neuropsychology, 14(3), 211-226.
56. van Tol, M., van der Wee., N., Demenescu, L., Nielen, M., Aleman, A., Renken, R., Veltman, D. J. (2011). Functional MRI correlates of visuospatial planning in out-patient Depression and Anxiety. Acta Psychiatra Scandinavica, 124(4), 273-284.